🇺🇸 Meloxicam 15 milligram in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 11

Most-reported reactions

1. Product Use In Unapproved Indication — 2 reports (18.18%)
2. Abdominal Pain Upper — 1 report (9.09%)
3. Activated Partial Thromboplastin Time Abnormal — 1 report (9.09%)
4. Chest Pain — 1 report (9.09%)
5. Coagulation Factor Viii Level Decreased — 1 report (9.09%)
6. Drug Ineffective — 1 report (9.09%)
7. Drug Ineffective For Unapproved Indication — 1 report (9.09%)
8. Drug Screen False Positive — 1 report (9.09%)
9. Ecchymosis — 1 report (9.09%)
10. Haematoma — 1 report (9.09%)

Source database →

Frequently asked questions

Is Meloxicam 15 milligram approved in United States?

Meloxicam 15 milligram does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Meloxicam 15 milligram in United States?

InnovaGyn, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.